D-Leucine
D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro[1].
Product Specifications
CAS Number
328-38-1
Product Name Alternative
(R) -Leucine
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/d-leucine.html
Purity
98.0
Solubility
DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N[C@H](CC(C)C)C(O)=O
Molecular Formula
C6H13NO2
Molecular Weight
131.18
Precautions
H302, H315, H319, H335
References & Citations
[1]Xiaoyu Cao, et al. Combination of PARP Inhibitor and Temozolomide to Suppress Chordoma Progression. J Mol Med (Berl) . 2019 Aug;97 (8) :1183-1193
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Serum Amyloid P / APCS (APCS/3240), Biotin conjugate, 0.1mg/mL